TrialInflammatory bowel diseases2025

Mediators of Filgotinib Treatment Effects in Ulcerative Colitis: Exploring Circulating Biomarkers in the Phase 2b/3 SELECTION Study.

Hiroshi Nakase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.